Delivery Order SPE2DR25D3014-SPE2DR26FP1DN
Award Date 11/25/25
Potential Completion Date 11/26/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,437.80 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100 count) on August 7, 2025, with completion scheduled for August 8, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $22,810.07 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Vyvanse 40mg capsules, with an ultimate completion date of December 1, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award based on the contractor's capability to meet federal procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100-count units) on November 25, 2025, with a ceiling value of $2,810.47 and completion date of November 26, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The order will be fulfilled from the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vyvanse capsules 40mg, with a ceiling value of $21,361.13. This is a firm fixed price delivery order with an ultimate completion date of November 7, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a $1,946.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg on September 18, 2025, with completion scheduled for September 19, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,278.24 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, with an ultimate completion date of November 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Vyvanse 60 mg capsules (100-count units) valued at $1,783.60 with a firm fixed price structure. This competitively awarded, non-set-aside contract is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order is scheduled for...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.07 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100 count) on November 20, 2025, with completion scheduled for November 21, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $3,398.49 to AmerisourceBergen Drug Corp for the supply of Vyvanse 10 mg capsules (100 count) on November 7, 2025, with completion scheduled for November 10, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,871.85 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg on September 26, 2025, with completion scheduled for September 29, 2025. This competitive award, issued under a firm fixed-price delivery order contract type, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...